On top of the risks of injecting untested and potentially contaminated products, user error may make this runaway wellness fad even more dangerous.
Articles on Food and Drug Administration (FDA)
Displaying 1 - 20 of 191 articles
A standardized framework for regulating the safety and efficacy of AI in healthcare has yet to be established.
This year, decisions from the courts, FDA or DOJ could all shut down telehealth for medication abortion, which is how most people in states with bans get care.
Flavored vapes draw new users – especially young people. On the flipside, they can also help some people quit smoking. Makary’s resignation makes it clear that the controversy isn’t going away.
The recall potentially affects more than 1 million people. It is the second time the FDA has found sterility issues at the company in three years.
Hallucinogenic chocolate bars were removed from six Denver-area gas stations.
After pushback, the agency reversed course and agreed to review Moderna’s application after all.
The move signals an escalation in the agency’s efforts to interfere with established procedures for testing and approving vaccines.
Judges and federal regulators will make significant decisions over Americans’ reproductive rights.
The agency’s plan to change the well-established process for safety testing vaccines is not realistic.
The drug information sheets that the FDA requires companies to produce are living documents that get updated with new information.
Most of the products the study tested contained much less lead than the FDA deems unsafe, but some did have a concerning amount.
Decades of research show that SSRIs can be safely used during pregnancy. Meanwhile, untreated depression during pregnancy is associated with poor health outcomes like preterm birth and preeclampsia.
Health insurance companies use AI to decide which health care treatment to cover. State laws and federal agencies are now moving toward regulating these algorithms.
Can the president fire leaders of more than 50 independent agencies overseen by Congress because he wants to? The Supreme Court may say yes, upending decades of constitutional law.
A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs. In his book, he compares the harm of the food and tobacco industries.
Public records requested under the Freedom of Information Act have helped shape health policy and keep the government accountable – but recent staff cuts may make this impossible.
Health Secretary Robert F. Kennedy Jr.’s new vision for US health policy prioritizes deregulation and leaves Americans with fewer benefits, services and protections.
The US economy has always been a mix of government regulation and market forces. The balance between those has shifted over time, but never has one side or the other been substantively removed.
Overseeing the FDA, NIH and several other public health and medical research divisions, the HHS secretary is a powerful force in how the nation accesses health care.
Top contributors
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor of Law, Villanova University
-
Associate Professor of Pharmacy and Therapeutics, University of Pittsburgh
-
Associate Professor of Public Policy, University of Maryland, Baltimore County
-
Associate Professor of Pediatrics, University of Virginia
-
Assistant Professor of Health Promotion and Policy, UMass Amherst
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Associate Professor of Obstetrics, Gynecology and Gynecologic Surgery, University of California, San Francisco
-
Associate Professor of Molecular Medicine, UMass Chan Medical School
-
Professor and Dean, School of Public Health, Georgia State University
-
Instructor of Human Immunology, Emory University
-
Associate Professor of Legal Studies and Political Science, UMass Amherst
-
Adjunct Associate Professor of Epidemiology, University of California, Los Angeles
-
Associate Professor of Operations and Decision Technologies, Kelley School of Business, Indiana University
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina